Lobbying Relationship

Client

Eli Lilly and Company

More records

Lobbying firm

The Ingram Group LLC

More records

  • General issues related to the biopharmaceutical and pharmaceutical industries including drug importation; H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017.
  • Issues related to tax reform; H.R.1, Tax Cuts and Jobs Act (P.L.115-97).

Duration: to

General Issues: Pharmacy, Taxation/Internal Revenue Code, Health Issues

Spending: about $510,000 (But it's complicated. Here's why.)

Agencies lobbied since 2015: U.S. Senate, House of Representatives

Bills mentioned

H.R.1628: American Health Care Act of 2017

Sponsor: Diane Black (R-Tenn.)

S.2030: Advancing Targeted Therapies for Rare Diseases Act of 2016

Sponsor: Michael Bennet (D-Colo.)

H.R.34: 21st Century Cures Act

Sponsor: Suzanne Bonamici (D-Ore.)

H.R.2028: Further Continuing and Security Assistance Appropriations Act, 2017

Sponsor: Mike Simpson (R-Idaho)

H.R.6: 21st Century Cures Act

Sponsor: Fred Upton (R-Mich.)

H.R.3116: Quarterly Financial Report Reauthorization Act

Sponsor: Ted Lieu (D-Calif.)

S.3004: Alaska Native Claims Settlement Improvement Act of 2016

Sponsor: Lisa Murkowski (R-Alaska)

H.R.1: An Act to provide for reconciliation pursuant to titles II and V of the...

Sponsor: Kevin Brady (R-Texas)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Tom Ingram CoS,Sen.LamarAlexander;StaffDir,SenRepubConf
Bernard Toon SrStaff,SenForeignRel;COSDorganBingamanBidenBradleyRoemer
Beecher Frasier Chief of Staff, Congressman Lincoln Davis
Daniel M. McCarthy Legislative Asst, WH Office of Legislative Affairs
Jeffrey Wiener Legislative Assistant, Senator Mary Landrieu
Jennifer Johnson Jarrell Legislative Assistant, U.S. Representative Joel Hefley
John Milne n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page